472 Results for GLP-1 Pipeline Update
  • Recapping Prime’s 21st annual Specialty Summit

    Marquee event showcased new Prime, our energy, ambition and transformative journey

    PA Sub-Categories: Specialty drugs Prime Article: Perspectives
  • AMCP Nexus 2024 - PDFs

    Methodological Framework for Propensity Adjusted Benchmarks for Pharmacy Key Performance Indicators The purpose of the study was to create a methodological framework for using propensity score...

  • Prime/MRx experts share clinical insights for migraine treatment

    Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs

    Prime Article: Stories
  • Our history

    Empowering client, providers and members 2024: Using real-time pricing, Pharmacy Match drives affordability for plan sponsors while offering access to the most competitive pharmacy for each member....

  • High-Cost Therapy Profile: June 2024

    Clinical deep dive Disease state overview Myelodysplastic syndromes (MDS) are classified as disorders in which there are abnormal (dysplastic) hematopoietic stem cells in the bone marrow, leading...

  • Brand Awareness Landing Page

    Whitepaper Tab 1 Myth 1 Myth 2 Myth 3 Myth 4 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed nec ornare mi. Praesent ultrices ipsum eget est rutrum, eget congue orci molestie. Sed diam...

  • 2024 Employer Market Insights Report

    Prime is pleased to present the seventh edition of the Employer Market Insights Report. Within this one-of-a-kind publication, you’ll find critical pharmacy trend insights that will help you make...

  • April Fraud Focus: The latest schemes and FWA trends

    Jessica Johnson, clinical consultant at Prime Therapeutics, shares how the Special Investigations Unit (SIU) helps prevent fraud, waste and abuse (FWA) in health care

    Prime Article: Perspectives